These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24697219)

  • 1. De novo EEF1A2 mutations in patients with characteristic facial features, intellectual disability, autistic behaviors and epilepsy.
    Nakajima J; Okamoto N; Tohyama J; Kato M; Arai H; Funahashi O; Tsurusaki Y; Nakashima M; Kawashima H; Saitsu H; Matsumoto N; Miyake N
    Clin Genet; 2015 Apr; 87(4):356-61. PubMed ID: 24697219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild epileptic phenotype associates with de novo eef1a2 mutation: Case report and review.
    De Rinaldis M; Giorda R; Trabacca A
    Brain Dev; 2020 Jan; 42(1):77-82. PubMed ID: 31477274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EEF1A2 mutations in epileptic encephalopathy/intellectual disability: Understanding the potential mechanism of phenotypic variation.
    Long K; Wang H; Song Z; Yin X; Wang Y
    Epilepsy Behav; 2020 Apr; 105():106955. PubMed ID: 32062104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel de novo EEF1A2 missense mutations causing epilepsy and intellectual disability.
    Lam WW; Millichap JJ; Soares DC; Chin R; McLellan A; FitzPatrick DR; Elmslie F; Lees MM; Schaefer GB; ; Abbott CM
    Mol Genet Genomic Med; 2016 Jul; 4(4):465-74. PubMed ID: 27441201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of early-onset myoclonic seizures with continuous parietal delta activity caused by EEF1A2 mutations.
    Inui T; Kobayashi S; Ashikari Y; Sato R; Endo W; Uematsu M; Oba H; Saitsu H; Matsumoto N; Kure S; Haginoya K
    Brain Dev; 2016 May; 38(5):520-4. PubMed ID: 26682508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Developmental and epileptic encephalopathy 33 caused by
    He HL; Lin XQ; Wang XL; Peng P; Xiao H; Yin F; Peng J
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Aug; 26(8):861-864. PubMed ID: 39148392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autism- and epilepsy-associated
    Mohamed MS; Klann E
    Proc Natl Acad Sci U S A; 2023 Sep; 120(38):e2307704120. PubMed ID: 37695913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency.
    Berryer MH; Hamdan FF; Klitten LL; Møller RS; Carmant L; Schwartzentruber J; Patry L; Dobrzeniecka S; Rochefort D; Neugnot-Cerioli M; Lacaille JC; Niu Z; Eng CM; Yang Y; Palardy S; Belhumeur C; Rouleau GA; Tommerup N; Immken L; Beauchamp MH; Patel GS; Majewski J; Tarnopolsky MA; Scheffzek K; Hjalgrim H; Michaud JL; Di Cristo G
    Hum Mutat; 2013 Feb; 34(2):385-94. PubMed ID: 23161826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DYRK1A mutations in two unrelated patients.
    Ruaud L; Mignot C; Guët A; Ohl C; Nava C; Héron D; Keren B; Depienne C; Benoit V; Maystadt I; Lederer D; Amsallem D; Piard J
    Eur J Med Genet; 2015 Mar; 58(3):168-74. PubMed ID: 25641759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders.
    McLachlan F; Sires AM; Abbott CM
    Hum Mutat; 2019 Feb; 40(2):131-141. PubMed ID: 30370994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recessive DEAF1 mutation associates with autism, intellectual disability, basal ganglia dysfunction and epilepsy.
    Rajab A; Schuelke M; Gill E; Zwirner A; Seifert F; Morales Gonzalez S; Knierim E
    J Med Genet; 2015 Sep; 52(9):607-11. PubMed ID: 26048982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
    Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
    J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of a de novo c.2605C > T (p.Pro869Ser) change in the MED13L gene and review of the literature for MED13L-related intellectual disability.
    Yi Z; Zhang Y; Song Z; Pan H; Yang C; Li F; Xue J; Qu Z
    Ital J Pediatr; 2020 Jul; 46(1):95. PubMed ID: 32646507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recapitulation of the EEF1A2 D252H neurodevelopmental disorder-causing missense mutation in mice reveals a toxic gain of function.
    Davies FCJ; Hope JE; McLachlan F; Marshall GF; Kaminioti-Dumont L; Qarkaxhija V; Nunez F; Dando O; Smith C; Wood E; MacDonald J; Hardt O; Abbott CM
    Hum Mol Genet; 2020 Jun; 29(10):1592-1606. PubMed ID: 32160274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
    Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
    Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous EEF1A2 mutation causes dilated cardiomyopathy, failure to thrive, global developmental delay, epilepsy and early death.
    Cao S; Smith LL; Padilla-Lopez SR; Guida BS; Blume E; Shi J; Morton SU; Brownstein CA; Beggs AH; Kruer MC; Agrawal PB
    Hum Mol Genet; 2017 Sep; 26(18):3545-3552. PubMed ID: 28911200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
    Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
    Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A de novo mutation in RPL10 causes a rare X-linked ribosomopathy characterized by syndromic intellectual disability and epilepsy: A new case and review of the literature.
    Bourque DK; Hartley T; Nikkel SM; Pohl D; Tétreault M; Kernohan KD; ; Dyment DA
    Eur J Med Genet; 2018 Feb; 61(2):89-93. PubMed ID: 29066376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel VPS13B Mutations in Three Large Pakistani Cohen Syndrome Families Suggests a Baloch Variant with Autistic-Like Features.
    Rafiq MA; Leblond CS; Saqib MA; Vincent AK; Ambalavanan A; Khan FS; Ayaz M; Shaheen N; Spiegelman D; Ali G; Amin-ud-Din M; Laurent S; Mahmood H; Christian M; Ali N; Fennell A; Nanjiani Z; Egger G; Caron C; Waqas A; Ayub M; Rasheed S; Forgeot d'Arc B; Johnson A; So J; Brohi MQ; Mottron L; Ansar M; Vincent JB; Xiong L
    BMC Med Genet; 2015 Jun; 16():41. PubMed ID: 26104215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.